We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Recursion Pharmaceuticals
RXRX
$1.6B
| $3.9M | 0.01% |
+391,518
| New | +$4.36M |
|
1077
News Corp Class A
NWSA
$14.8B
| $3.9M | 0.01% |
149,090
-261,597
| -64% | -$6.64M |
|
1078
WisdomTree
WT
$3.01B
| $3.89M | 0.01% |
423,693
+97,350
| +30% | +$745K |
|
1079
iShares MBS ETF
MBB
$39.1B
| $3.88M | 0.01% |
+42,000
| New | +$3.88M |
|
1080
Kyverna Therapeutics
KYTX
$481M
| $3.87M | 0.01% |
+155,755
| New | +$4.35M |
|
|
RVNC
1081
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.84M | 0.01% |
+781,223
| New | +$4.62M |
|
1082
Banco de Chile
BCH
$20.9B
| $3.84M | 0.01% |
+172,504
| New | +$3.88M |
|
1083
InvenTrust Properties
IVT
$2.83B
| $3.83M | 0.01% |
148,926
-177,169
| -54% | -$4.46M |
|
1084
Arch Capital
ACGL
$36.3B
| $3.82M | 0.01% |
+41,300
| New | +$3.49M |
|
1085
PUT
Alibaba
BABA
$276B
| $3.82M | 0.01% |
48,000
-38,500
| -45% | -$2.82M |
|
1086
Ascendis Pharma A/S
ASND
$16.6B
| $3.79M | 0.01% |
+25,084
| New | +$3.58M |
|
1087
IMAX
IMAX
$2.47B
| $3.79M | 0.01% |
234,317
-552,710
| -70% | -$8.4M |
|
1088
Ardagh Metal Packaging
AMBP
$2.89B
| $3.78M | 0.01% |
1,103,351
-191,573
| -15% | -$686K |
|
|
FLDDW
1089
CALL
Fold Holdings Warrant
FLDDW
$1.3M
| $3.78M | 0.01% |
356,086
-100,000
| -22% | -$9.17K |
|
1090
Wolfspeed
WOLF
$1.24B
| $3.77M | 0.01% |
+127,900
| New | +$3.86M |
|
1091
TransDigm Group
TDG
$71.9B
| $3.77M | 0.01% |
+3,062
| New | +$3.45M |
|
1092
Lindblad Expeditions
LIND
$1.84B
| $3.75M | 0.01% |
402,365
+59,837
| +17% | +$551K |
|
1093
iShares China Large-Cap ETF
FXI
$4.22B
| $3.74M | 0.01% |
155,500
+120,900
| +349% | +$2.79M |
|
1094
Clearwater Paper
CLW
$278M
| $3.73M | 0.01% |
85,402
+12,503
| +17% | +$461K |
|
1095
Atkore
ATKR
$2.54B
| $3.72M | 0.01% |
+19,544
| New | +$3.13M |
|
1096
GeoPark
GPRK
$615M
| $3.72M | 0.01% |
387,443
+315,736
| +440% | +$2.81M |
|
1097
Teleflex
TFX
$5.8B
| $3.72M | 0.01% |
16,431
-127,181
| -89% | -$30.2M |
|
1098
PUT
Comcast
CMCSA
$80.9B
| $3.71M | 0.01% |
+93,500
| New | +$4.03M |
|
1099
Paymentus
PAY
$3.96B
| $3.69M | 0.01% |
162,231
+56,293
| +53% | +$1.02M |
|
|
MDC
1100
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.69M | 0.01% |
+58,600
| New | +$3.58M |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.